ris På dag 30 reducerede fondaparinux signifikant den samlede mortalitetsincidens fra 3, 5% for enoxaparin til 2, 9% (hazard rate 0, 83; 95% CI 0, 71- 0, 97; p = 0, 02).
By Day 30, the incidence of all cause mortality was significantly reduced from 3.5% on enoxaparin to 2.9% on fondaparinux (hazard ratio 0.83, 95% CI, 0.71; 0.97, p = 0.02).